These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26160355)

  • 1. Oral cholera vaccine protects against endemic disease, real life trial shows.
    Mayor S
    BMJ; 2015 Jul; 351():h3730. PubMed ID: 26160355
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of a Single-Dose, Inactivated Oral Cholera Vaccine in Bangladesh.
    Qadri F; Wierzba TF; Ali M; Chowdhury F; Khan AI; Saha A; Khan IA; Asaduzzaman M; Akter A; Khan A; Begum YA; Bhuiyan TR; Khanam F; Chowdhury MI; Islam T; Chowdhury AI; Rahman A; Siddique SA; You YA; Kim DR; Siddik AU; Saha NC; Kabir A; Cravioto A; Desai SN; Singh AP; Clemens JD
    N Engl J Med; 2016 May; 374(18):1723-32. PubMed ID: 27144848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. When should cholera vaccine be used in cholera-endemic areas?
    Sack DA
    J Health Popul Nutr; 2003 Dec; 21(4):299-303. PubMed ID: 15038584
    [No Abstract]   [Full Text] [Related]  

  • 4. Urgent need of cholera vaccines in public health-control programs.
    Clemens J; Holmgren J
    Future Microbiol; 2009 May; 4(4):381-5. PubMed ID: 19416006
    [No Abstract]   [Full Text] [Related]  

  • 5. Feasibility and effectiveness of oral cholera vaccine in an urban endemic setting in Bangladesh: a cluster randomised open-label trial.
    Qadri F; Ali M; Chowdhury F; Khan AI; Saha A; Khan IA; Begum YA; Bhuiyan TR; Chowdhury MI; Uddin MJ; Khan JAM; Chowdhury AI; Rahman A; Siddique SA; Asaduzzaman M; Akter A; Khan A; Ae You Y; Siddik AU; Saha NC; Kabir A; Riaz BK; Biswas SK; Begum F; Unicomb L; Luby SP; Cravioto A; Clemens JD
    Lancet; 2015 Oct; 386(10001):1362-1371. PubMed ID: 26164097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholera vaccines.
    Kabir S
    Lancet Infect Dis; 2007 Mar; 7(3):176-8; author reply 178. PubMed ID: 17317594
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial.
    Sur D; Lopez AL; Kanungo S; Paisley A; Manna B; Ali M; Niyogi SK; Park JK; Sarkar B; Puri MK; Kim DR; Deen JL; Holmgren J; Carbis R; Rao R; Nguyen TV; Donner A; Ganguly NK; Nair GB; Bhattacharya SK; Clemens JD
    Lancet; 2009 Nov; 374(9702):1694-702. PubMed ID: 19819004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of oral cholera vaccine as a vaccine probe to determine the burden of culture-negative cholera.
    Im J; Islam MT; Ahmmed F; Kim DR; Chon Y; Zaman K; Khan AI; Ali M; Marks F; Qadri F; Clemens JD
    PLoS Negl Trop Dis; 2019 Mar; 13(3):e0007179. PubMed ID: 30870416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholera in Bangladesh.
    Wkly Epidemiol Rec; 2015 Oct; 90(40):539-42. PubMed ID: 26433983
    [No Abstract]   [Full Text] [Related]  

  • 10. Cholera in Africa: new momentum in fighting an old problem.
    Mengel MA
    Trans R Soc Trop Med Hyg; 2014 Jul; 108(7):391-2. PubMed ID: 24836060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of oral cholera vaccine in a stable refugee population at risk for epidemic cholera and in a population with endemic cholera.
    Murray J; McFarland DA; Waldman RJ
    Bull World Health Organ; 1998; 76(4):343-52. PubMed ID: 9803585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of cholera vaccines reassessed.
    Glass RI; Steele AD
    Lancet; 2005 Jul 2-8; 366(9479):7-9. PubMed ID: 15993211
    [No Abstract]   [Full Text] [Related]  

  • 13. Estimating the cost of cholera-vaccine delivery from the societal point of view: A case of introduction of cholera vaccine in Bangladesh.
    Sarker AR; Islam Z; Khan IA; Saha A; Chowdhury F; Khan AI; Cravioto A; Clemens JD; Qadri F; Khan JA
    Vaccine; 2015 Sep; 33(38):4916-21. PubMed ID: 26232545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preface.
    Holmgren J
    Vaccine; 2020 Feb; 38 Suppl 1():A1-A3. PubMed ID: 31402237
    [No Abstract]   [Full Text] [Related]  

  • 15. Optimized oral cholera vaccine distribution strategies to minimize disease incidence: A mixed integer programming model and analysis of a Bangladesh scenario.
    Smalley HK; Keskinocak P; Swann J; Hinman A
    Vaccine; 2015 Nov; 33(46):6218-23. PubMed ID: 26458806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crisis-driven cholera resurgence switches focus to oral vaccine.
    Bull World Health Organ; 2018 Jul; 96(7):446-447. PubMed ID: 29962546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral cholera vaccines in endemic countries.
    O'Leary M; Mulholland K
    Lancet; 2015 Oct; 386(10001):1321-1322. PubMed ID: 26164098
    [No Abstract]   [Full Text] [Related]  

  • 18. Development of Peru-15 (CholeraGarde), a live-attenuated oral cholera vaccine: 1991-2009.
    Chowdhury MI; Sheikh A; Qadri F
    Expert Rev Vaccines; 2009 Dec; 8(12):1643-52. PubMed ID: 19943759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-Dose Oral Cholera Vaccine in Bangladesh.
    Azman AS; Luquero FJ
    N Engl J Med; 2016 Aug; 375(7):e12. PubMed ID: 27532851
    [No Abstract]   [Full Text] [Related]  

  • 20. Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis.
    Ali M; Emch M; von Seidlein L; Yunus M; Sack DA; Rao M; Holmgren J; Clemens JD
    Lancet; 2005 Jul 2-8; 366(9479):44-9. PubMed ID: 15993232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.